Gyre Therapeutics, Inc.

GYRE ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
8-K	Sep 1, 2026	8-K
S-8	Aug 31, 2026	S-8
8-K	Aug 26, 2026	8-K
10-Q	Aug 7, 2026	10-Q
8-K	Aug 7, 2026	8-K
4	Aug 4, 2026	FORM 4
4	Aug 4, 2026	FORM 4
3	Aug 4, 2026	FORM 3
3	Aug 4, 2026	FORM 3
EFFECT	Aug 3, 2026
8-K	Jul 16, 2026	8-K
8-K/A	Jul 15, 2026	8-K/A
S-3/A	Jul 13, 2026	S-3/A
4	Jun 30, 2026	FORM 4
4	Jun 30, 2026	FORM 4
4	Jun 30, 2026	FORM 4
4	Jun 30, 2026	FORM 4
4	Jun 30, 2026	FORM 4
4	Jun 30, 2026	FORM 4
S-3	Jun 23, 2026	S-3
4	Jun 22, 2026	FORM 4
8-K	Jun 16, 2026	8-K
4	Jun 15, 2026	FORM 4
4	Jun 11, 2026	FORM 4
4	Jun 10, 2026	FORM 4

← Newer Page 1 of 65 · 1601 filings Older →